EUVIMEDEUVIMED entdecken
Crossref

Exploiting KREC: Time for newborn screening and beyond—proceedings from the First International KREC Consortium Meeting

Paola R Suhet, Jordan Abbott, Roshini S Abraham, Mei W Baker, Oksana Boyarchuk, Karlla W Brigatti, Manish J Butte, Christopher Chang, Hey Chong, Antonio Condino-Neto, Zsuzsanna Gaál, Mariana P Gouveia-Pereira und 12 weitere

Journal of Allergy and Clinical Immunology · 2026-11 · 158 (5) · 1218-1225

DOI: 10.1016/j.jaci.2026.09.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-11. Verfasst von Paola R Suhet und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Pediatrics, University of South Florida, Morsani College of Medicine, Tampa, Fla; Division of Aller…. Hauptthemen laut MEDLINE: Lymphopenia, Neonatal Screening, Severe Combined Immunodeficiency. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newborn screening (NBS) for severe combined immunodeficiency using T-cell receptor excision circles has changed the diagnosis and outcomes for infants with profound T-cell lymphopenia. However, patients with severe B-cell lymphopenia are still typically diagnosed only after serious or recurrent infections or irreversible complications. Some countries now measure kappa-deleting recombination excision circles (KREC) together with T-cell receptor excision circles to identify infants with severe B-cell lymphopenia, but adoption remains limited. The First International KREC Consortium Meeting, held in Tampa, Florida, in February 2026, convened clinicians, laboratory scientists, public health experts, patient advocates, and families from North America, Europe, Asia, and South America to review current experience and implementation strategies for broader KREC screening. Sessions covered international screening programs, laboratory methods, assay harmonization, interpretation and reporting, clinical impact of early diagnosis, therapeutic options, and policy pathways for implementation. Patients and families shared personal experiences of delayed diagnosis and perspectives on NBS. The meeting identified key priorities for future implementation, including the justification of this assay on the basis of impact in patient care and feasibility for integration into current NBS approaches on the basis of health-economic evaluation. Once implemented, next steps include harmonization of methods and reporting, strategies to minimize false-positive results and referrals, and follow-up pathways. These proceedings summarize the major discussions and outline priorities for collaborative evidence generation and future implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphopeniaNeonatal ScreeningSevere Combined ImmunodeficiencyHumansInfant, NewbornReceptors, Antigen, T-Cell

Stichwörter der Autor:innen

KRECNewborn screeningX-linked agammaglobulinemiaagammaglobulinemiainborn errors of immunitysevere B-cell lymphopenia

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Department of Pediatrics, University of South Florida, Morsani College of Medicine, Tampa, Fla; Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins All Childre…
  • Division of Allergy and Immunology, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colo.
  • Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Wisconsin State Laboratory of Hygiene and Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
  • Department of Children's Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical Universiry, Ternopil, Ukraine.
  • Clinic for Special Children, Gordonville, Pa.

Zitieren

APA

Suhet, P. R., Abbott, J., Abraham, R. S., Baker, M. W., Boyarchuk, O., Brigatti, K. W., Butte, M. J., Chang, C., Chong, H., Condino-Neto, A., Gaál, Z., Gouveia-Pereira, M. P., Grunebaum, E., Hartono, S., Kanegane, H., Pham-Huy, A., de Oliveira-Junior, E. B., Raj, R., Seroogy, C. M., …, & Walter, J. E. (2026). Exploiting KREC: Time for newborn screening and beyond—proceedings from the First International KREC Consortium Meeting. Journal of Allergy and Clinical Immunology, 158(5), 1218-1225. https://doi.org/10.1016/j.jaci.2026.09.003

Vancouver

Suhet PR, Abbott J, Abraham RS, Baker MW, Boyarchuk O, Brigatti KW, et al. Exploiting KREC: Time for newborn screening and beyond—proceedings from the First International KREC Consortium Meeting. Journal of Allergy and Clinical Immunology. 2026;158(5):1218-1225. doi:10.1016/j.jaci.2026.09.003

BibTeX
@article{Suhet2026,
  author = {Suhet, Paola R and Abbott, Jordan and Abraham, Roshini S and Baker, Mei W and Boyarchuk, Oksana and Brigatti, Karlla W and Butte, Manish J and Chang, Christopher and Chong, Hey and Condino-Neto, Antonio and Gaál, Zsuzsanna and Gouveia-Pereira, Mariana P and Grunebaum, Eyal and Hartono, Stella and Kanegane, Hirokazu and Pham-Huy, Anne and de Oliveira-Junior, Edgar Borges and Raj, Revathi and Seroogy, Christine M and Soler-Palacin, Pere and Somech, Raz and Tenembaum, Vanessa and van der Burg, Mirjam and Walter, Jolan E},
  title = {Exploiting KREC: Time for newborn screening and beyond—proceedings from the First International KREC Consortium Meeting},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {158},
  number = {5},
  pages = {1218--1225},
  doi = {10.1016/j.jaci.2026.09.003}
}
Kostenlos starten →